Kite, a Gilead Company

@KitePharma

Our singular focus is , which we believe has the ability to change the way cancer is treated. See our guidelines:

Vrijeme pridruživanja: svibanj 2015.

Tweetovi

Blokirali ste korisnika/cu @KitePharma

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @KitePharma

  1. 4. velj

    "As we look ahead to the next 30 years, there is reason to be more energized than ever about the path forward." - Kite CEO Christi Shaw on .

    Poništi
  2. 4. velj

    What is the bravest thing we can do about ? Come together, says Kite CEO Christi Shaw.

    Poništi
  3. 3. velj

    We all know someone who has been affected by . On February 4, join us in raising awareness by sharing how you’re committed to reducing the impact of the disease.

    Poništi
  4. 29. sij

    We are pleased to join and at the 2nd European CAR T Cell Meeting in Sitges, Spain this week to discuss the latest research in

    Poništi
  5. 28. sij

    Today the Marketing Authorization Application for our second therapy was validated for review by the European Medicines Agency

    Poništi
  6. 21. sij

    We were honored to attend ’s Researcher Day in Maryland today and discuss the future of

    Poništi
  7. 21. sij

    : Engineered TCR therapies are currently being investigated for the potential treatment of various solid tumors and blood cancers?

    Poništi
  8. 16. sij

    Our team in Amsterdam (Hoofddorp) is growing! See what a day in the life of a Cell Therapy Specialist (CTS) there looks like.

    Poništi
  9. 10. sij

    manufacturing is a unique and highly scientific process that requires continual innovation and rapid turnaround

    Poništi
  10. 6. sij
    Poništi
  11. What a year! We’re ringing in the New Year with excitement as we continue to drive forward. See you in 2020!

    Poništi
  12. At Kite, we’re advancing technology. Take a closer look at how works.

    Poništi
  13. Kite employees helped spread holiday cheer by donating toys for underserved children and teens in the Southern California area today.

    Poništi
  14. We were honored to host the Women at Gilead SoCal Chapter’s Career Development and Networking Event with Kimberly Lathroum (), and at our Kite headquarters in Santa Monica last night.

    Poništi
  15. Today we announced submission of a filing for our second therapy

    Poništi
  16. Poništi
  17. has come to an end, but there’s still more to come from us. Keep following along on Twitter for more on our advancing portfolio!

    Poništi
  18. Thank you to everyone who stopped by our booth to learn about Kite’s pipeline in at

    Poništi
  19. 9. pro 2019.

    that mantle cell lymphoma (MCL) begins in the cells in the outer edge of the lymph node?

    Poništi
  20. 9. pro 2019.

    We’re sharing results from the first evaluation of therapy in mantle cell (MCL). Head to Hall D at 3:30pm to join the conversation.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·